Tel Aviv University researchers have developed one of the first experimental models for eosinophilic gastritis – an allergic disease of the stomach. The model helped identify the immune pathways responsible the disease and has led to a new generation of biologic therapies.
Gastritis model leads to new allergy treatments
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.